Cargando…

Endoscopic injection sclerotherapy for pediatric bleeding esophageal varices complicated by gastric vein, main portal vein, splenic mesenteric junction, and splenic vein occlusion: a case report

BACKGROUND: Endoscopic injection sclerotherapy (EIS) is a life-saving procedure for pediatric patients with bleeding gastric varices (GV) associated with advanced liver cirrhosis and severe portal hypertension. Because of the lack of an endoscopic banding ligation device for pediatric patients, EIS...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, King-Wah, Lin, Ting-Lung, Yong, Chee-Chien, Lin, Chih-Che, Cheng, Yu-Fan, Chen, Chao-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396477/
https://www.ncbi.nlm.nih.gov/pubmed/30819091
http://dx.doi.org/10.1186/s12876-019-0955-7
_version_ 1783399260207710208
author Chiu, King-Wah
Lin, Ting-Lung
Yong, Chee-Chien
Lin, Chih-Che
Cheng, Yu-Fan
Chen, Chao-Long
author_facet Chiu, King-Wah
Lin, Ting-Lung
Yong, Chee-Chien
Lin, Chih-Che
Cheng, Yu-Fan
Chen, Chao-Long
author_sort Chiu, King-Wah
collection PubMed
description BACKGROUND: Endoscopic injection sclerotherapy (EIS) is a life-saving procedure for pediatric patients with bleeding gastric varices (GV) associated with advanced liver cirrhosis and severe portal hypertension. Because of the lack of an endoscopic banding ligation device for pediatric patients, EIS is usually performed for bleeding esophageal varices (EV) in infants with congenital biliary atresia. CASE PRESENTATION: We present a case of a 15-month-old female infant with type I biliary atresia with jaundice (total serum bilirubin, 22.2 mg/dL), hypoalbuminemia (serum albumin level, 2.58 g/dL), coagulopathy (prothrombin time > 20 s compared with that of a normal control), ascites, splenomegaly, portal hypertension (portal vein velocity, 3.9–5.6 cm/sec of hepatopetal flow), and repeated bleeding of the varices after receiving three doses of intravascularly administered Histoacryl 1 ampoule mixed with Lipiodol UF 8 mL in the EV. Prominent GV and EV were occluded by EIS. The sclerosing agent was also present in the main portal vein, splenic mesenteric junction, and splenic vein, causing an engorged inferior mesenteric vein. The patient underwent total hepatectomy and living donor liver transplantation (LDLT) by left lateral segment graft (segments 2, 3, and 4 of the middle hepatic vein trunk) and left portal vein graft to the recipient inferior mesenteric vein anastomosis. Portal vein stent placement via segment 4 of the portal vein stump was performed from the inferior mesenteric vein to the umbilical portion of the left portal vein. The patient is still alive and doing well after the LDLT. CONCLUSIONS: EIS is a life-saving procedure in cases involving bleeding EV complicated by gastric, main portal vein, splenic mesenteric junction, and splenic vein occlusions; hence, it should be kept in mind as a treatment for EV complications in pediatric patients.
format Online
Article
Text
id pubmed-6396477
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63964772019-03-13 Endoscopic injection sclerotherapy for pediatric bleeding esophageal varices complicated by gastric vein, main portal vein, splenic mesenteric junction, and splenic vein occlusion: a case report Chiu, King-Wah Lin, Ting-Lung Yong, Chee-Chien Lin, Chih-Che Cheng, Yu-Fan Chen, Chao-Long BMC Gastroenterol Case Report BACKGROUND: Endoscopic injection sclerotherapy (EIS) is a life-saving procedure for pediatric patients with bleeding gastric varices (GV) associated with advanced liver cirrhosis and severe portal hypertension. Because of the lack of an endoscopic banding ligation device for pediatric patients, EIS is usually performed for bleeding esophageal varices (EV) in infants with congenital biliary atresia. CASE PRESENTATION: We present a case of a 15-month-old female infant with type I biliary atresia with jaundice (total serum bilirubin, 22.2 mg/dL), hypoalbuminemia (serum albumin level, 2.58 g/dL), coagulopathy (prothrombin time > 20 s compared with that of a normal control), ascites, splenomegaly, portal hypertension (portal vein velocity, 3.9–5.6 cm/sec of hepatopetal flow), and repeated bleeding of the varices after receiving three doses of intravascularly administered Histoacryl 1 ampoule mixed with Lipiodol UF 8 mL in the EV. Prominent GV and EV were occluded by EIS. The sclerosing agent was also present in the main portal vein, splenic mesenteric junction, and splenic vein, causing an engorged inferior mesenteric vein. The patient underwent total hepatectomy and living donor liver transplantation (LDLT) by left lateral segment graft (segments 2, 3, and 4 of the middle hepatic vein trunk) and left portal vein graft to the recipient inferior mesenteric vein anastomosis. Portal vein stent placement via segment 4 of the portal vein stump was performed from the inferior mesenteric vein to the umbilical portion of the left portal vein. The patient is still alive and doing well after the LDLT. CONCLUSIONS: EIS is a life-saving procedure in cases involving bleeding EV complicated by gastric, main portal vein, splenic mesenteric junction, and splenic vein occlusions; hence, it should be kept in mind as a treatment for EV complications in pediatric patients. BioMed Central 2019-02-28 /pmc/articles/PMC6396477/ /pubmed/30819091 http://dx.doi.org/10.1186/s12876-019-0955-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Chiu, King-Wah
Lin, Ting-Lung
Yong, Chee-Chien
Lin, Chih-Che
Cheng, Yu-Fan
Chen, Chao-Long
Endoscopic injection sclerotherapy for pediatric bleeding esophageal varices complicated by gastric vein, main portal vein, splenic mesenteric junction, and splenic vein occlusion: a case report
title Endoscopic injection sclerotherapy for pediatric bleeding esophageal varices complicated by gastric vein, main portal vein, splenic mesenteric junction, and splenic vein occlusion: a case report
title_full Endoscopic injection sclerotherapy for pediatric bleeding esophageal varices complicated by gastric vein, main portal vein, splenic mesenteric junction, and splenic vein occlusion: a case report
title_fullStr Endoscopic injection sclerotherapy for pediatric bleeding esophageal varices complicated by gastric vein, main portal vein, splenic mesenteric junction, and splenic vein occlusion: a case report
title_full_unstemmed Endoscopic injection sclerotherapy for pediatric bleeding esophageal varices complicated by gastric vein, main portal vein, splenic mesenteric junction, and splenic vein occlusion: a case report
title_short Endoscopic injection sclerotherapy for pediatric bleeding esophageal varices complicated by gastric vein, main portal vein, splenic mesenteric junction, and splenic vein occlusion: a case report
title_sort endoscopic injection sclerotherapy for pediatric bleeding esophageal varices complicated by gastric vein, main portal vein, splenic mesenteric junction, and splenic vein occlusion: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396477/
https://www.ncbi.nlm.nih.gov/pubmed/30819091
http://dx.doi.org/10.1186/s12876-019-0955-7
work_keys_str_mv AT chiukingwah endoscopicinjectionsclerotherapyforpediatricbleedingesophagealvaricescomplicatedbygastricveinmainportalveinsplenicmesentericjunctionandsplenicveinocclusionacasereport
AT lintinglung endoscopicinjectionsclerotherapyforpediatricbleedingesophagealvaricescomplicatedbygastricveinmainportalveinsplenicmesentericjunctionandsplenicveinocclusionacasereport
AT yongcheechien endoscopicinjectionsclerotherapyforpediatricbleedingesophagealvaricescomplicatedbygastricveinmainportalveinsplenicmesentericjunctionandsplenicveinocclusionacasereport
AT linchihche endoscopicinjectionsclerotherapyforpediatricbleedingesophagealvaricescomplicatedbygastricveinmainportalveinsplenicmesentericjunctionandsplenicveinocclusionacasereport
AT chengyufan endoscopicinjectionsclerotherapyforpediatricbleedingesophagealvaricescomplicatedbygastricveinmainportalveinsplenicmesentericjunctionandsplenicveinocclusionacasereport
AT chenchaolong endoscopicinjectionsclerotherapyforpediatricbleedingesophagealvaricescomplicatedbygastricveinmainportalveinsplenicmesentericjunctionandsplenicveinocclusionacasereport